Gateway 2011: Abbott Laboratories - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: Abbott Laboratories


Your online Gateway to Abbott Laboratories in 2011

Abbott Laboratories
1401 Sheridan Road
North Chicago, IL 60064
1-800-240-1043
www.abbottcontractmfg.com



Abbott is a broad-based, global health care company devoted to the discovery, development, manufacture and marketing of products that span the continuum of care, from nutritionals and laboratory diagnostics through medical devices and pharmaceutical therapies. We advance leading-edge science and technologies that hold the potential for improving lives. And we’ve sustained our success by staying true to the key principles on which our company was founded more than a century ago: innovative care and a desire to make a meaningful difference in all that we do. As a world leader in pharmaceutical operations, Abbott can provide your company with global contract services to help you help you gain a competitive advantage. We work with partners who value quality healthcare as much as we do.

Join us at BIO (Abbott Booth: 2805) and CPhI (Abbott Booth: 42H39) in 2011 to learn more about our API and Contract Manufacturing Services.

Active Pharmaceutical Ingredients
-Multi compendia APIs (USP/EP/JP)

Biologics
-Cell line development
-Mammalian cell culture
-Process development
-Process characterization
-Pilot thru full scale commercial production

Finished Goods
-Manufacturing/Dosage
-Packaging

Potents/Cytotoxins
-Small scale production
-API commercial production
-Finished goods production

We invite you to partner with us as we help translate your science into healthier lives around the world.

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here